Oliver Keminer

1.3k total citations
24 papers, 711 citations indexed

About

Oliver Keminer is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Oliver Keminer has authored 24 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Oliver Keminer's work include Pluripotent Stem Cells Research (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Computational Drug Discovery Methods (3 papers). Oliver Keminer is often cited by papers focused on Pluripotent Stem Cells Research (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Computational Drug Discovery Methods (3 papers). Oliver Keminer collaborates with scholars based in Germany, Italy and Portugal. Oliver Keminer's co-authors include Angela Rohwedder, Ole Pleß, Jan Peter Siebrasse, Reiner Peters, Elisabeth Schneider, Katja Schneider, Johannes Förster, Hermann Werchau, Gesche Ketels and Sina C. Rosenkranz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Bioinformatics and The Science of The Total Environment.

In The Last Decade

Oliver Keminer

23 papers receiving 703 citations

Peers

Countries citing papers authored by Oliver Keminer

Since Specialization

Citations

This map shows the geographic impact of Oliver Keminer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Keminer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Keminer more than expected).

Fields of papers citing papers by Oliver Keminer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Keminer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Keminer. The network helps show where Oliver Keminer may publish in the future.

Co-authorship network of co-authors of Oliver Keminer

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Keminer. A scholar is included among the top collaborators of Oliver Keminer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Keminer. Oliver Keminer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The fast‐dissociating D ₂ antagonist antipsychotic JNJ‐37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment 2025 ·British Journal of Pharmacology ·(unknown), Oliver Keminer, (unknown), Andrea Zaliani, Antonio Leo, (unknown), Caterina De Sarro, (unknown), (unknown), Sarah Weckhuysen, Jeanette Reinshagen, Vincenzo Barrese, Natascia Guida, Carmine Ostacolo, Francesco Miceli, Philip Gribbon, Maurizio Taglialatela	2
2	SAR Study of 4,8-Disubstituted Pyrimido[5,4-d]pyrimidines Exhibiting Antitrypanosomal and Antileishmanial Activity 2024 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), Nuno Santarém, (unknown), (unknown), Oliver Keminer, Sheraz Gul, Anabela Cordeiro‐da‐Silva, M. Alice Carvalho	1
3	Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents 2024 ·ACS Infectious Diseases ·(unknown), Nuno Santarém, (unknown), (unknown), (unknown), Alessandra Altomare, Giulio Ferrario, (unknown), Oliver Keminer, Giancarlo Aldini, Lucia Tamborini, Nicoletta Basilico, Silvia Parapini, Sheraz Gul, Anabela Cordeiro‐da‐Silva, Paola Conti, Chiara Borsari	4
4	Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches 2022 ·Cancers ·(unknown), Leanne Stevenson, (unknown), (unknown), (unknown), Oliver Keminer, Björn Windshügel, Daniela M. Zisterer, Richard D. Kennedy, Jaine K. Blayney, Richard Turkington	3
5	A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection 2021 ·Scientific Data ·Bernhard Ellinger, Denisa Bojková, Andrea Zaliani, Jindřich Činátl, Carsten Claussen, Sandra Westhaus, Oliver Keminer, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geißlinger, Philip Gribbon, Sandra Ciesek	52
6	Droplet-based vitrification of adherent human induced pluripotent stem cells on alginate microcarrier influenced by adhesion time and matrix elasticity 2021 ·Cryobiology ·(unknown), (unknown), Alisa Katsen‐Globa, André Schulz, (unknown), Frank Stracke, (unknown), (unknown), Oliver Keminer, Ole Pleß, John O. Gardner, Carsten Claussen, Philip Gribbon, Julia C. Neubauer, Heiko Zimmermann	7
7	Nelfinavir and Its Active Metabolite M8 Are Partial Agonists and Competitive Antagonists of the Human Pregnane X Receptor 2021 ·Molecular Pharmacology ·Oliver Burk, Thales Kronenberger, Oliver Keminer, Serene M. L. Lee, Tobias S. Schiergens, Matthias Schwab, Björn Windshügel	8
8	An automated and high-throughput-screening compatible pluripotent stem cell-based test platform for developmental and reproductive toxicity assessment of small molecule compounds 2020 ·Cell Biology and Toxicology ·Gesa Witt, Oliver Keminer, (unknown), Rashmi Tandon, (unknown), Anne Willing, (unknown), (unknown), Björn Brändl, (unknown), Manuel A. Friese, Frank Müller, Julia C. Neubauer, Carsten Claussen, Heiko Zimmermann, Philip Gribbon, Ole Pleß	10
9	The COVID-19 Ontology 2020 ·Bioinformatics ·(unknown), Alpha Tom Kodamullil, Shounak Baksi, (unknown), Sumit Madan, Stephan Gebel, Oliver Keminer, (unknown), (unknown), (unknown), Manfred Köhler, Marc Jacobs, Martin Hofmann‐Apitius	23
10	Identification of novel agonists by high-throughput screening and molecular modelling of human constitutive androstane receptor isoform 3 2019 ·Archives of Toxicology ·Oliver Keminer, Björn Windshügel, Frank Eßmann, Serene M. L. Lee, Tobias S. Schiergens, Matthias Schwab, Oliver Burk	4
11	A tiered high-throughput screening approach for evaluation of estrogen and androgen receptor modulation by environmentally relevant bisphenol A substitutes 2019 ·The Science of The Total Environment ·Oliver Keminer, Matthias Teigeler, Manfred Köhler, Andrea Wenzel, Jürgen Arning, (unknown), Björn Windshügel, (unknown)	44
12	Generation of two human isogenic iPSC lines from fetal dermal fibroblasts 2018 ·Stem Cell Research ·Rashmi Tandon, Björn Brändl, (unknown), Alexandro Landshammer, Laura Steenpaß, Oliver Keminer, Ole Pleß, Frank Müller	12
13	A high-content small molecule screen identifies novel inducers of definitive endoderm 2017 ·Molecular Metabolism ·(unknown), (unknown), Oliver Keminer, Kamyar Hadian, Kenji Schorpp, Philip Gribbon, Heiko Lickert	27
14	Enforced polarization of melanoma cells towards a JARID1B-high phenotype exhausts tumour fitness 2017 ·RWTH Publications (RWTH Aachen) ·Heike Chauvistré, Oliver Keminer, Andrea Sechi, Daniel Picard, Marc Remke, Meenhard Herlyn, Felix C. E. Vogel, (unknown), (unknown), (unknown), Alexander Roesch, Clemens Krepler, Dirk Schadendorf, (unknown), (unknown), (unknown), (unknown), Batool Shannan, Nikolas K. Haass	0
15	Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis 2016 ·Journal of Neuroimmunology ·(unknown), Sina C. Rosenkranz, Oliver Keminer, Stefan Patra, Gesche Ketels, Christoph Heesen, Rainer Hellweg, Ole Pleß, Karl‐Heinz Schulz, Stefan M. Gold	93
16	IL-17 production by CSF lymphocytes as a biomarker for cerebral vasculitis 2016 ·Neurology Neuroimmunology & Neuroinflammation ·(unknown), (unknown), Mathias Gelderblom, (unknown), Manuela Kolster, Simon Schuster, Götz Thomalla, Oliver Keminer, Ole Pleß, Christian Bernreuther, Markus Glatzel, Karl Wegscheider, Christian Gerloff, Tim Magnus, Eva Tolosa	21
17	Novel MK2 Inhibitors by Fragment Screening 2009 ·Combinatorial Chemistry & High Throughput Screening ·Oliver Keminer, (unknown), Jan D. Kahmann, (unknown), Christoph Scheich, Joern Jungmann, Sabine Schaertl, Dirk Winkler, Osamu Ichihara, Mark Whittaker, Dirk Ullmann, Thomas Hesterkamp	4
18	Permeability of Single Nuclear Pores 1999 ·Biophysical Journal ·Oliver Keminer, (unknown)	198
19	Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction 1998 ·Journal of Medical Virology ·Angela Rohwedder, Oliver Keminer, Johannes Förster, Katja Schneider, Elisabeth Schneider, Hermann Werchau	61
20	Detection of HPV DNA in trichilemmomas by polymerase chain reaction 1997 ·Journal of Medical Virology ·Angela Rohwedder, Oliver Keminer, (unknown), Jörg Schaller	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact